In 2022, automated breast ultrasound systems industry was valued at USD 1.7 billion and will grow at 15.5% CAGR from 2023 to 2032, attributed to the rising prevalence of breast cancer globally.
ABUS industry size is expected to be worth USD 4.5 billion by 2032, attributed to rapid advancements in ABUS devices.
North America ABUS market share was nearly 20% in 2022, driven by growing healthcare spending in the region.
Prominent ABUS industry players include Volpara Solutions Limited, Hitachi Ltd., Shantou Institute of Ultrasonic Instruments Co., Ltd (SIUI), CapeRay Medical, Seno Medical Instruments Inc., and Siemens AG, among others.